A Mysterious
Rash
Zokir Takhirov 190169
Clinical Case Presentation – The
Patient
• Case:
• A 35-year-old African American
woman presents with a 3-month
history of multiple skin
lesions on her face and arms.
• Mild cough and occasional
shortness of breath.
• No fever, weight loss, or systemic
symptoms.
• No history of similar lesions or
trauma.
Initial Dermatologic
Examination
• Multiple violaceous, indurated
plaques on the nose and cheeks.
• Several brownish-red papules on
the forearms.
• No pustules, vesicles, or ulcerations.
Differential Diagnosis of Papulonodular
Lesions
Granuloma annulare
Lupus
erythematosus
Sarcoidosis
Leprosy Cutaneous tuberculosis
Condition Clinical Clues Histology Other Tests
Red-brown papules/plaques, often on Non-caseating ↑ ACE, hypercalcemia,
Sarcoidosis
face or scars; lupus pernio (nose) granulomas CXR: hilar adenopathy
Lupus Basal vacuolar
Malar rash, photosensitivity, discoid ANA (+), anti-dsDNA
erythematos degeneration, perivascular
plaques (+)
us lymphocytes
Granuloma Annular, flesh-colored plaques, often Degenerated collagen, Self-limited, no
annulare on extremities palisading histiocytes systemic markers
Chronic ulcers, verrucous plaques; Caseating granulomas TB skin test (+), PCR,
Cutaneous TB
endemic areas with acid-fast bacilli culture
Hypopigmented anesthetic patches Granulomas with acid- Skin slit smear,
Leprosy
(tuberculoid), nodules (lepromatous) fast bacilli Lepromin test
Punch Excision
al
Skin Biopsy
A biopsy of the papular lesion was performed.
Biopsy results
•Histopathology: Non-caseating
granulomas in the dermis without
central necrosis.
•Negative for fungal or mycobacterial
organisms.
Systemic • Pulmonary function tests: Mild
restrictive pattern.
Evaluation
Lab tests
•↑ Serum ACE – Due to granuloma-associated
macrophages.
•Hypercalcemia & Hypercalciuria – Macrophages in
granulomas produce 1α-hydroxylase, increasing
vitamin D activation.
•↑ Alkaline phosphatase (ALP) – If liver involvement is
present.
•↓ Lymphocyte count (Lymphopenia) – Due to
sequestration in granulomas.
•↑ CD4/CD8 ratio in bronchoalveolar lavage (BAL)
(>3.5)
Sarcoidosis!
Sarcoidosis
Definition: Chronic granulomatous disease
of unknown etiology, characterized by non-
caseating granulomas in multiple organs.
Pathophysiology:
• Immune dysregulation: Exaggerated Th1
response → ↑ IFN-γ & TNF-α → macrophage
activation → granuloma formation.
• Non-caseating granulomas: Composed of
epithelioid macrophages, multinucleated
giant cells, and lymphocytes.
Sarcoidosis Subtypes in
Dermatology
Plaque
sarcoidosis
Papular sarcoidosis – Most Lupus pernio – Chronic, disfiguring
common; brown-red papules on plaques on the nose, cheeks, and ears.
the face and trunk.
Erythema nodosum –
Tender subcutaneous
nodules on the legs
(often self-limited). •Scar sarcoidosis – Old scars
Subcutaneous Nodular
sarcoidosis become raised and inflamed. sarcoidosis
Treatment Options
•First-line:
Topical/intralesional
steroids.
•Severe cases: Systemic
corticosteroids (prednisone).
•Steroid-sparing agents:
Methotrexate,
hydroxychloroquine.
•Refractory cases: TNF-
alpha inhibitors (infliximab).
Cutaneous sarcoidosis may resolve
spontaneously or persist.
Prognosis Lupus pernio = worse prognosis
(associated with chronic pulmonary disease).
Spontaneous resolution: ~60% of cases,
especially with isolated hilar adenopathy.
Chronic disease: ~30%, with progressive
fibrosis in lungs or other organs.
Severe complications: ~10%, including
pulmonary hypertension, cardiac involvement,
or neurosarcoidosis.
Mortality: ~1-5%, mainly from respiratory
failure, cardiac arrhythmias, or CNS disease.
Skin findings can be the
first clue to systemic
Final sarcoidosis.
Always biopsy suspicious
Takeawa lesions to confirm
ys & granulomas.
Rule out TB and
Discussio infections before
n diagnosing sarcoidosis.
Multidisciplinary approach:
Dermatology +
Pulmonology.
Definition: Chronic granulomatous disease of unknown etiology, Cardiac Manifestations (5%)
characterized by non-caseating granulomas in multiple organs.
• Conduction abnormalities: AV block is most common.
Pathophysiology: • Restrictive or dilated cardiomyopathy.
• Immune dysregulation: Exaggerated Th1 response → ↑ IFN-γ &
TNF-α → macrophage activation → granuloma formation. Neurologic Manifestations (5-10%)
• Non-caseating granulomas: Composed of epithelioid • Facial nerve palsy (Bell’s palsy).
macrophages, multinucleated giant cells, and lymphocytes. • Meningitis, seizures, or peripheral neuropathy.
Pulmonary Manifestations (Most Common, ~90%) Other Systemic Features
• Bilateral hilar lymphadenopathy (BHL): Classic CXR finding. • Löfgren syndrome: BHL, erythema nodosum, fever,
• Interstitial lung disease: Reticular opacities, fibrosis (restrictive polyarthritis (good prognosis).
pattern). • Heerfordt syndrome: Uveitis, parotitis, fever, facial nerve
• Hypercalcemia: Due to increased 1α-hydroxylase in palsy.
granulomas → ↑ 1,25-(OH)₂D.
Diagnosis:
Dermatologic Manifestations (30%) • CXR: BHL, interstitial lung disease.
• Lupus pernio: Violaceous plaques on nose, cheeks, ears • Serum ACE ↑ (nonspecific).
(specific for sarcoidosis). • Hypercalcemia (↑ 1,25-vitamin D).
• Erythema nodosum: Tender red nodules on shins (good • Biopsy: Non-caseating granulomas (gold standard).
prognosis, often self-limiting).
• Maculopapular lesions: Common but non-specific. Treatment:
• Asymptomatic or mild cases: Observation.
Ophthalmologic Manifestations (25%)
• Symptomatic (lungs, eyes, heart, neuro): Corticosteroids
• Uveitis: Blurred vision, photophobia, conjunctival granulomas. are first-line.
• Sicca syndrome: Lacrimal gland involvement → dry eyes. • Refractory cases: Methotrexate, TNF-α inhibitors
Summary
A: Waxy interscapular skin plaques – cutaneous
sarcoidosis.
B: Lupus pernio – violaceous facial plaques, a chronic
sarcoidosis feature.
C: Anterior uveitis with synechiae – ocular
involvement, common in sarcoidosis.
D: Enlarged, nodular lacrimal gland – sarcoid-related
lacrimal gland involvement.
E: Endobronchial cobblestoning – bronchial sarcoidosis.
F: Peripheral facial-nerve palsy with hearing loss –
Heerfordt syndrome.
G: Spinal cord mass – neurosarcoidosis.
H: Multi-organ involvement on gallium scan –
sarcoidosis distribution.
I: Hypermetabolic liver, spleen, and lymph nodes – PET
scan of sarcoidosis.
J: Aspergilloma in lung cavity – sarcoid-associated
fungal colonization.
K: Hypodense splenic nodules – splenic sarcoidosis.
L: Optic chiasm involvement – neurosarcoidosis with
visual risk.
M: Granulomatous humeral lesion – bone sarcoidosis.
Summary of sarcoidosis
Reference
1. AE Lopez-Sundh, T Maestre-Orozco, MC Gonzalez-Vela, & M Fernandez-Ayala. (2021). Subcutaneous sarcoidosis. Journal of Postgraduate Medicine, 67(3), 154–157.
https://doi.org/10.4103/jpgm.jpgm_1072_20
2. Dr. Aye Min Htoo. (2021, November 28). Dr. Aye Min Htoo - Dermatologist & Author. https://drayeminhtoo.com/lupus-vulgaris/
3. Girod, B., & Crowley, K. (2023a, July 31). Leprosy could become endemic to Florida. Here is what to know. USA TODAY; Pensacola News Journal.
https://www.usatoday.com/story/news/health/2023/07/31/leprosy-florida-outbreak-symptoms-causes/70499618007/
4. Girod, B., & Crowley, K. (2023b, July 31). Leprosy could become endemic to Florida. Here is what to know. USA TODAY; Pensacola News Journal.
https://www.usatoday.com/story/news/health/2023/07/31/leprosy-florida-outbreak-symptoms-causes/70499618007/
5. Hudson, M. (2017, July 21). The Stages of Pulmonary Sarcoidosis- What Do They Really Mean? Foundation for Sarcoidosis Research. https://www.stopsarcoidosis.org/stages-of-
sarcoidosis/
6. Pasquali, P., Gonzalez, S., Fortuño, A., & Azael Freites-Martinez. (2019). In-vivo assessment of a case of cutaneous sarcoidosis using reflectance confocal microscopy. Anais Brasileiros
de Dermatologia, 94(1), 93–95. https://doi.org/10.1590/abd1806-4841.20197315
7. Pathology of Lupus Vulgaris (Cutaneous Tuberculosis) - Dr Sampurna Roy MD. (2022). Histopathology-India.net. https://www.histopathology-india.net/lupus_vulgaris.htm
8. Rodrigues, T., Rocha, E., & Barcelos, A. (2017). Ocular and parotid sarcoidosis - panda sign. Acta Reumatológica Portuguesa; https://www.semanticscholar.org/paper/Ocular-and-
parotid-sarcoidosis-panda-sign.-Rodrigues-Rocha/2203e280bc3e5f4c775d68b35c9bf2ff88ea4771
9. Sarcoidosis, Erythema Nodosum – Sleep and Lung Care. (2018, September 24). Sleepandlungcare.com.au. https://sleepandlungcare.com.au/lung-cancer-the-basics/sarcoidosis-erythema-
nodosum/
10. Sève, P., Pacheco, Y., Durupt, F., Jamilloux, Y., Gerfaud-Valentin, M., Isaac, S., Boussel, L., Calender, A., Androdias, G., Valeyre, D., & El Jammal, T. (2021). Sarcoidosis: A Clinical
Overview from Symptoms to Diagnosis. Cells, 10(4), 766. https://doi.org/10.3390/cells10040766
11. Sifuentes, A. (2024a, March 14). Linkedin.com. https://www.linkedin.com/posts/w-alberto-sifuentes-giraldo-7213997b_sarcoidosis-activity-7174033726975180800-m-Qa
12. Sifuentes, A. (2024b, March 14). Linkedin.com. https://www.linkedin.com/posts/w-alberto-sifuentes-giraldo-7213997b_sarcoidosis-activity-7174033726975180800-m-Qa
13. Singh, S., Sharma, B. B., Mohan Bairwa, Dipti Gothi, & Raghu, G. (2020). Management of Interstitial Lung Diseases: A consensus statement of the Indian Chest Society (ICS) and
National College of Chest Physicians (NCCP ). Lung India, 37(4), 360–374.
https://www.researchgate.net/publication/342623307_Management_of_Interstitial_Lung_Diseases_A_consensus_statement_of_the_Indian_Chest_Society_ICS_and_National_College_
of_Chest_Physicians_NCCP
14. Stagaki, E., Mountford, W. K., Lackland, D. T., & Judson, M. A. (2008). The Treatment of Lupus Pernio. CHEST Journal, 135(2), 468–476. https://doi.org/10.1378/chest.08-1347
15. (2020). Jcdr.net. https://www.jcdr.net/ReadXMLFile.aspx?id=14009
16. (2025a). Amboss.com. https://media-us.amboss.com/media/thumbs/big_6638e96fa54049.74654041.jpg
17. (2025b). Mbscf.com. https://media-us.mbscf.com/media/thumbs/big_5dfa49d483e12.jpg
18. (2025c). Sarcoidosisnews.com. https://sarcoidosisnews.com/wp-content/uploads/2019/11/shutterstock_570694897_zpscj873mxl-1200x900-cropped.jpg
19. (2025d). Sciencephoto.com. https://media.sciencephoto.com/c0/52/20/29/c0522029-800px-wm.jpg
20. (2025e). Grepmed.com. https://img.grepmed.com/uploads/9187/syndrome-diagnosis-lofgren-original.jpeg
21. Gerke, A. K. (2020). Treatment of Sarcoidosis: A Multidisciplinary Approach. Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.545413
22. Iannuzzi, M. C., Rybicki, B. A., & Teirstein, A. S. (2007). Sarcoidosis. New England Journal of Medicine, 357(21), 2153–2165. https://doi.org/10.1056/nejmra071714